Mesothelin Targeted Cancer Immunotherapy

European Journal of Cancer - United Kingdom
doi 10.1016/j.ejca.2007.08.028
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Mesothelin, a Novel Immunotherapy Target for Triple Negative Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

Mesothelin Expression in Advanced Gastroesophageal Cancer Represents a Novel Target for Immunotherapy

Applied Immunohistochemistry and Molecular Morphology
Forensic MedicinePathologyMedical Laboratory TechnologyHistology
2016English

Treating Penile Cancer in the Immunotherapy and Targeted Therapy Era

Case Reports in Oncological Medicine
Oncology
2019English

Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors

Cancer Discovery
Oncology
2015English

Targeted IL-15-based Protein Fusion Complexes as Cancer Immunotherapy Approaches

Journal of Immunological Sciences
2018English

Tumor Targeted Nanocarriers for Immunotherapy

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2020English

Targeted Therapies to Improve Tumor Immunotherapy

Clinical Cancer Research
Cancer ResearchOncology
2008English

The Hen Model of Human Ovarian Cancer Develops Anti-Mesothelin Autoantibodies in Response to Mesothelin Expressing Tumors

Journal of Ovarian Research
GynecologyOncologyObstetrics
2011English

Clinicopathological Significance of Mesothelin Expression in Invasive Breast Cancer

Journal of International Medical Research
BiochemistryMedicineCell Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy